• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

性别-年龄-生理学评分小于或等于3分的轻度纤维化间质性肺病患者病情进展的预测因素。

Predictive factors of progression in mild fibrosing interstitial lung disease patients with gender-age-physiology score of 3 or less.

作者信息

Okamoto Masaki, Fujimoto Kiminori, Chikasue Tomonori, Yanagihara Toyoshi, Tabata Kazuhiro, Zaizen Yoshiaki, Tominaga Masaki, Sumi Akiko, Takeoka Hiroaki, Matsuo Norikazu, Nouno Takashi, Kawaguchi Atsushi, Hoshino Tomoaki

机构信息

Department of Respirology, NHO Kyushu Medical Center, 1-8-1 Jigyohama, Chuo-ku, Fukuoka, 810-0065, Japan; Division of Respirology, Neurology, and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume, Fukuoka, 830-0011, Japan.

Department of Radiology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, Fukuoka, 830-0011, Japan.

出版信息

Respir Investig. 2025 Jan;63(1):109-117. doi: 10.1016/j.resinv.2024.12.005. Epub 2024 Dec 16.

DOI:10.1016/j.resinv.2024.12.005
PMID:39689588
Abstract

BACKGROUND

The prognostic factors in mild fibrosing interstitial lung disease (FILD) have not been established.

METHODS

We retrospectively attempted to identify predictive factors of annual progression in mild FILD with gender-age-physiology (GAP) score of 3 or less using logistic regression analysis. Annual FILD progression was defined as meeting any two or more of the following conditions: 1, more than 10% decrease in forced vital capacity (FVC) or 15% decrease in diffusing capacity of the lungs for carbon monoxide (D); 2, worsening of dyspnea; 3, worsening of fibrotic change on CT at 1 year after admission.

RESULTS

Univariate analysis showed that diagnosis of connective tissue disease-associated ILD, CT-definite usual interstitial pneumonia (UIP) pattern, composite physiologic index, FVC, D, lowest SpO and decrease in SpO, and walk distance in the 6-minutes walk test (6MWT), chronic pulmonary emphysema assessment test (CAT) score, and some variables in Short-Form 36 were significantly associated with incidence of annual progression. Multivariate analysis showed that independent predictive factors were diagnosis of idiopathic pulmonary fibrosis (IPF) and fibrotic hypersensitivity pneumonitis (HP), CT-definite UIP pattern, lowest SpO and decrease in SpO in the 6MWT, and CAT score. In logistic regression analysis among 63 patients with non-IPF-ILD, diagnosis with fibrotic HP, lowest SpO and decrease in SpO in the 6MWT, and CAT score were also independent risk factors for annual FILD progression.

CONCLUSIONS

Exercise-induced hypoxia, patient-reported outcome, radiological UIP pattern, and diagnosis with fibrotic HP are independent predictors of annual progression in mild FILD.

摘要

背景

轻度纤维化间质性肺疾病(FILD)的预后因素尚未明确。

方法

我们采用逻辑回归分析,回顾性地试图确定性别 - 年龄 - 生理学(GAP)评分≤3的轻度FILD患者年度病情进展的预测因素。年度FILD进展定义为符合以下任何两项或更多条件:1. 用力肺活量(FVC)下降超过10%或肺一氧化碳弥散量(D)下降15%;2. 呼吸困难加重;3. 入院后1年CT显示纤维化改变加重。

结果

单因素分析显示,结缔组织病相关间质性肺病的诊断、CT明确的普通型间质性肺炎(UIP)模式、综合生理指数、FVC、D、最低SpO₂以及SpO₂下降、6分钟步行试验(6MWT)中的步行距离、慢性阻塞性肺疾病评估测试(CAT)评分以及简明健康状况调查问卷(SF-36)中的一些变量与年度病情进展发生率显著相关。多因素分析显示,独立预测因素为特发性肺纤维化(IPF)和纤维化性过敏性肺炎(HP)的诊断、CT明确的UIP模式、6MWT中的最低SpO₂以及SpO₂下降和CAT评分。在63例非IPF-ILD患者的逻辑回归分析中,纤维化性HP的诊断、6MWT中的最低SpO₂以及SpO₂下降和CAT评分也是FILD年度病情进展的独立危险因素。

结论

运动诱导的低氧血症、患者报告的结果、放射学UIP模式以及纤维化性HP的诊断是轻度FILD患者年度病情进展的独立预测因素。

相似文献

1
Predictive factors of progression in mild fibrosing interstitial lung disease patients with gender-age-physiology score of 3 or less.性别-年龄-生理学评分小于或等于3分的轻度纤维化间质性肺病患者病情进展的预测因素。
Respir Investig. 2025 Jan;63(1):109-117. doi: 10.1016/j.resinv.2024.12.005. Epub 2024 Dec 16.
2
Comparison of clinical courses and mortality of connective tissue disease-associated interstitial pneumonias and chronic fibrosing idiopathic interstitial pneumonias.结缔组织病相关性间质性肺炎与慢性纤维化特发性间质性肺炎的临床过程和死亡率比较。
Kaohsiung J Med Sci. 2019 Jun;35(6):365-372. doi: 10.1002/kjm2.12066. Epub 2019 Mar 26.
3
Factors influencing long-term outcomes in fibrotic interstitial lung disease (F-ILD) diagnosed through multidisciplinary discussion (MDD): a prospective cohort study.多学科讨论(MDD)诊断的纤维化间质性肺疾病(F-ILD)中影响长期结局的因素:一项前瞻性队列研究。
Eur J Med Res. 2024 Jan 30;29(1):91. doi: 10.1186/s40001-024-01673-2.
4
Correlation of pulmonary function and usual interstitial pneumonia computed tomography patterns in idiopathic pulmonary fibrosis.特发性肺纤维化中肺功能与普通型间质性肺炎计算机断层扫描模式的相关性
Respir Med. 2017 Aug;129:152-157. doi: 10.1016/j.rmed.2017.06.013. Epub 2017 Jun 21.
5
Possible UIP pattern on high-resolution computed tomography is associated with better survival than definite UIP in IPF patients.高分辨率计算机断层扫描上可能的 UIP 模式与特发性肺纤维化患者的明确 UIP 相比与更好的生存相关。
Respir Med. 2017 Oct;131:229-235. doi: 10.1016/j.rmed.2017.08.025. Epub 2017 Sep 12.
6
Real-life experiences in a single center: efficacy of pirfenidone in idiopathic pulmonary fibrosis and fibrotic idiopathic non-specific interstitial pneumonia patients.单中心真实世界经验:吡非尼酮治疗特发性肺纤维化和特发性非特异性间质性肺炎纤维化患者的疗效。
Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620963015. doi: 10.1177/1753466620963015.
7
The performance of the GAP model in patients with rheumatoid arthritis associated interstitial lung disease.GAP模型在类风湿关节炎相关间质性肺疾病患者中的表现。
Respir Med. 2017 Jun;127:51-56. doi: 10.1016/j.rmed.2017.04.012. Epub 2017 Apr 22.
8
Exercise-Induced Oxygen Desaturation and Outcomes After Nintedanib Therapy for Fibrosing Interstitial Lung Disease in Patients Without Dyspnea.尼达尼布治疗无呼吸困难的纤维化间质性肺疾病患者后的运动诱导性氧饱和度下降及预后
J Clin Med. 2024 Dec 23;13(24):7865. doi: 10.3390/jcm13247865.
9
Prediction of progression of interstitial lung disease in patients with systemic sclerosis: the SPAR model.系统性硬化症患者间质性肺病进展的预测:SPAR 模型。
Ann Rheum Dis. 2018 Sep;77(9):1326-1332. doi: 10.1136/annrheumdis-2018-213201. Epub 2018 Jun 6.
10
Disease progression in idiopathic pulmonary fibrosis with mild physiological impairment: analysis from the Australian IPF registry.特发性肺纤维化合并轻度生理损害的疾病进展:来自澳大利亚特发性肺纤维化登记处的分析。
BMC Pulm Med. 2018 Jan 25;18(1):19. doi: 10.1186/s12890-018-0575-y.